Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Buy dildos and vibrators.
Popular Articles

New Research Shows: Neurofeedback Is An 'Evidence-Based' Treatment For ADHD
Neurofeedback - also called EEG Biofeedback - is a method used to train brain activity in order to normalize Brain function and treat psychiatric disorders. This treatment method has gained interest over the last 10 years, however the question whether this treatment should be regarded as an Evidence-Based treatment was unanswered until now. Tomorrow a study will be published in the scientific journal "EEG and Clinical Neuroscience" demonstrating that Neurofeedback can indeed be regarded as an evidence-based treatment for Attention Deficit- / Hyperactivity Disorder (ADHD).
buy viagra
Lack Of Happiness Hormone Serotonin In The Brain Causes Impaired Maternal Behavior In Mice
A lack of serotonin, commonly known as the "happiness hormone", in the brain slows the growth of mice after birth and is responsible for impaired maternal behavior later in life. This was the result of research conducted by Dr. Natalia Alenina, Dana Kikic, and Professor Michael Bader of the Max DelbrÃøck Center for Molecular Medicine (MDC) Berlin-Buch, Germany. At the same time, the researchers discovered that the presence of serotonin in the brain is not crucial for the survival of the animals. Furthermore, they were able to confirm that there are two strictly separate pathways of serotonin production: One gene is responsible for the formation of serotonin in the brain, another gene for the production of the hormone in the body (PNAS, June 23, 2009, Vol. 106, No. 25, pp 10332-10337)*.
News of the day
Oculus Innovative Sciences Receives FDA Clearance For Microcyn(R) Skin And Wound Gel
Oculus Innovative Sciences, Inc. (Nasdaq: OCLS), a healthcare company that develops, manufactures and markets a family of products based upon the Microcyn® Technology platform, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its Microcyn® Skin and Wound Gel as both a prescription and over-the-counter formulation. The Rx product, under the supervision of a health care professional, is intended for management of exuding wounds such as leg ulcers, pressure ulcers, diabetic ulcers and for the management of mechanically or surgically debrided wounds. This is the first hydrogel product based upon the Microcyn Technology platform and is reimbursable by both Medicare and Medicaid.
Medical Devices

Scientists Uncover Patterns Of Genetic Changes In Mental Retardation

Researchers at Radboud University Medical Centre, together with UK Medical Research Council scientists at Oxford University, have uncovered some of the central characteristics of genes underlying mental retardation. The research, which shortens the list of genes whose changes lead to this disorder from thousands to several dozen, is published June 26 in the open-access journal PLoS Genetics. Mental retardation, which affects approximately two percent of the population, is often caused by many different, yet individually rare DNA deletions and duplications. Pinpointing the DNA changes responsible has proven challenging precisely because these changes are not concentrated in a small number of genes. The scientists took DNA from over 150 individuals with mental retardation and compared it with descriptions of 5,000 mice whose genomes each had single genes disrupted. The researchers found that the DNA changes associated with mental retardation contained greater than expected numbers of genes whose loss in mice also affected the nervous system. The large amounts of data from humans and mice were critical in revealing a relatively small set of genes that are relevant to mental retardation in humans. This study provides strong evidence that genomic deletions and duplications frequently cause mental retardation. By narrowing down the list of genes linked to the disorder, the research will help to enable genetic testing and diagnosis. In the future, the approach used in this study could also prove effective in highlighting genes altered in other medical conditions such as schizophrenia and autism. In some countries, including the UK, mental retardation is more properly referred to by clinicians as learning difficulty. The following organisations provided funding for this work: UK Medical Research Council, Berrow Lord Florey scholarship, the Swiss National Science Foundation, the Netherlands Organisation for Health Research and Development, and the EU-sponsored AnEUploidy project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. CITATION: "Forging Links between Human Mental Retardation-Associated CNVs and Mouse Gene Knockout Models". Webber C, Hehir-Kwa JY, Nguyen D-Q, de Vries BBA, Veltman JA, et al. (2009) PLoS Genet 5(6): e1000531. doi:10.1371/journal.pgen.1000531 The Public Library of Science (PLoS)


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009